Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Esperion Therapeutics
(NASDAQ:ESPR)
Intraday
$1.90
-0.09
[-4.52%]
After-Hours
$1.90
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$1.90
-0.09
[-4.52%]
At close: Apr 26
$1.90
0
[0.00%]
After Hours: 7:49PM EDT
Get Report
Watch
Q1 2024 Earnings in 9 days from now on Tue May 7th, before the market open
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Esperion Therapeutics Stock (NASDAQ:ESPR)
Esperion Therapeutics Stock (NASDAQ: ESPR)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, April 12, 2024
Applied Digital Reports Downbeat Results, Joins Nurix Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Avi Kapoor
-
Apr 12, 2024, 8:04AM
Thursday, April 11, 2024
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
-
Apr 11, 2024, 1:33PM
Wednesday, April 10, 2024
Needham Reiterates Buy on Esperion Therapeutics, Maintains $8 Price Target
Benzinga Newsdesk
-
Apr 10, 2024, 6:48AM
Monday, April 08, 2024
Esperion Therapeutics shares are trading lower. The company announced the presentation of new data from CLEAR Outcomes.
Benzinga Newsdesk
-
Apr 8, 2024, 2:20PM
Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Apr 8, 2024, 5:15AM
Reported Sunday, Esperion Presents New Data From CLEAR Outcomes At ACC.24 Highlighting Value Of NEXLETOL® Tablets In Diverse Populations
Benzinga Newsdesk
-
Apr 8, 2024, 2:41AM
Wednesday, April 03, 2024
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Apr 3, 2024, 1:56PM
Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
-
Apr 3, 2024, 10:31AM
Monday, March 25, 2024
Esperion Announces Data from CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & Industry Expert Theatre To Be Presented At ACC.24
Benzinga Newsdesk
-
Mar 25, 2024, 4:01PM
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
-
Mar 25, 2024, 2:44PM
HC Wainwright & Co. Reiterates Buy on Esperion Therapeutics, Maintains $16 Price Target
Benzinga Newsdesk
-
Mar 25, 2024, 1:01PM
Why Is Heart Disease-Focused Esperion Therapeutics Stock Trading Higher On Monday?
Vandana Singh
-
Mar 25, 2024, 9:24AM
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Mar 25, 2024, 9:05AM
Market-Moving News for March 25th
Benzinga Newsdesk
-
Mar 25, 2024, 8:40AM
Why Salarius Pharmaceuticals Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Mar 25, 2024, 8:03AM
Needham Reiterates Buy on Esperion Therapeutics, Maintains $8 Price Target
Benzinga Newsdesk
-
Mar 25, 2024, 7:35AM
Esperion shares are trading higher after the FDA approved broad labels for NEXLETOL and NEXLIZET to prevent heart attacks and cardiovascular procedures, regardless of statin use.
Benzinga Newsdesk
-
Mar 25, 2024, 6:44AM
Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session
Avi Kapoor
-
Mar 25, 2024, 5:34AM
Friday, March 22, 2024
Esperion Therapeutics Inc Says European Cardiovascular Risk Reduction Label Determination Anticipated In Q2 2024
Benzinga Newsdesk
-
Mar 22, 2024, 3:13PM
U.S. FDA Approves Broad New Labels For NEXLETOL And NEXLIZET To Prevent Heart Attacks And Cardiovascular Procedures In Both Primary And Secondary Prevention Patients, Regardless Of Statin Use
Benzinga Newsdesk
-
Mar 22, 2024, 3:12PM
Daiichi Sankyo Europe GmbH And and Esperion Therapeutics Announce CHMP Issues Positive Opinions For Both Bempedoic Acid And The Bempedoic Acid / Ezetimibe Fixed-Dose Combination Tablet As Treatments For Hypercholesterolemia And Significantly Reducing Cardiovascular Events
Benzinga Newsdesk
-
Mar 22, 2024, 11:06AM
Wednesday, February 28, 2024
HC Wainwright & Co. Maintains Buy on Esperion Therapeutics, Lowers Price Target to $16
Benzinga Newsdesk
-
Feb 28, 2024, 1:21PM
Tuesday, February 27, 2024
Needham Reiterates Buy on Esperion Therapeutics, Maintains $8 Price Target
Benzinga Newsdesk
-
Feb 27, 2024, 2:47PM
Esperion Therapeutics Expects FY24 Operating Expenses Of $225M-$245M, Including $20M In Non-cash Expenses Related To Stock Compensation
Benzinga Newsdesk
-
Feb 27, 2024, 6:10AM
Esperion Therapeutics Q4 Retail Prescription Equivalents Grew 44% YoY, Projects Momentum Within Segment Into 1H 2024
Benzinga Newsdesk
-
Feb 27, 2024, 6:06AM
Esperion Therapeutics Q4 EPS $(0.50) Misses $(0.48) Estimate, Sales $32.25M Beat $28.70M Estimate
Benzinga Newsdesk
-
Feb 27, 2024, 6:03AM
Earnings Scheduled For February 27, 2024
Benzinga Insights
-
Feb 27, 2024, 5:01AM
Monday, February 26, 2024
Earnings Preview: Esperion Therapeutics
Benzinga Insights
-
Feb 26, 2024, 3:02PM
Tuesday, January 30, 2024
Peering Into Esperion Therapeutics's Recent Short Interest
Benzinga Insights
-
Jan 30, 2024, 1:00PM
Friday, January 19, 2024
Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Jan 19, 2024, 1:05PM
Why Super Micro Computer Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Jan 19, 2024, 8:13AM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Jan 19, 2024, 8:06AM
Esperion Prices $85.1M Public Offering Of 56.7M Common Share At $1.50/Share
Benzinga Newsdesk
-
Jan 19, 2024, 2:16AM
Thursday, January 18, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Jan 18, 2024, 4:31PM
Esperion Therapeutics Commences Public Offering Of Shares Of Its Common Stock; No Terms Disclosed
Benzinga Newsdesk
-
Jan 18, 2024, 4:01PM
Wednesday, January 17, 2024
Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Jan 17, 2024, 1:12PM
SolarEdge Technologies, Calavo Growers, Fisker And Other Big Stocks Moving Lower On Wednesday
Avi Kapoor
-
Jan 17, 2024, 11:18AM
Friday, January 12, 2024
Why Wipro Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Jan 12, 2024, 1:28PM
Wednesday, January 03, 2024
Nasdaq Down Over 100 Points; Sidus Space Shares Spike Higher
Avi Kapoor
-
Jan 3, 2024, 2:20PM
Why SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Jan 3, 2024, 12:58PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Jan 3, 2024, 12:31PM
Crude Oil Gains Over 3%; US Manufacturing Activity Contracts For 14th Consecutive Month
Avi Kapoor
-
Jan 3, 2024, 12:01PM
Esperion Therapeutics shares are trading lower after the company and Daiichi Sankyo Europe announced a $125 million amendment to their collaboration that included a resolution to its pending litigation.
Benzinga Newsdesk
-
Jan 3, 2024, 10:54AM
Why Pharmaceutical Company Esperion Therapeutics Shares Are Diving Today
Nabaparna Bhattacharya
-
Jan 3, 2024, 9:47AM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Jan 3, 2024, 8:05AM
Esperion And Daiichi Sankyo Europe Announce $125M Amendment To Their Collaboration Including Resolution Of Pending Litigation
Benzinga Newsdesk
-
Jan 3, 2024, 7:07AM
Friday, December 29, 2023
Global Mofy Metaverse Reports Follow-on Offering, Joins Lyft, Coinbase Global And Other Big Stocks Moving Lower On Friday
Avi Kapoor
-
Dec 29, 2023, 10:45AM
Thursday, December 28, 2023
Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
-
Dec 28, 2023, 1:07PM
Wednesday, December 20, 2023
Top 4 Health Care Stocks That May Crash This Month
Avi Kapoor
-
Dec 20, 2023, 8:31AM
Thursday, December 14, 2023
Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
-
Dec 14, 2023, 12:56PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch